Results 151 to 160 of about 2,465 (209)

The story of elimination of visceral leishmaniasis (kala-azar) in India-Challenges towards sustainment. [PDF]

PLoS Negl Trop Dis
Sundar S.
europepmc   +1 more source

Ensuring enantiomeric consistency in FAPI radiopharmaceuticals: comparative analysis of (S)- and (S/R)-FAPI-46/-74 confirms pharmacological equivalence. [PDF]

EJNMMI Radiopharm Chem
Staniszewska M, Hübner R, Locatelli C, Howard D, Forni M, Man F, Schoultz BW, Nuruddin S, Norberg-Schulz Hagen IS, Mosessian S, Herrmann K, von Kiedrowski V, Lückerath K.   +12 more
europepmc   +1 more source

A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations. [PDF]

Genome Med
Gonzalez Castro LN, Gavish A, Bussema L, Mount CW, Neftel C, Nomura M, Chiocca EA, Bi WL, Arnaout O, Barker FG, Brown JM, Jordan JT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR, Tirosh I, Suvà ML.   +16 more
europepmc   +1 more source

Smart Tattoo Sensors 2.0: A Ten-Year Progress Report through a Narrative Review. [PDF]

Bioengineering (Basel)
Pirrera A, Giansanti D.
europepmc   +1 more source

Synergistic Strategies of Biomolecular Transport Technologies in Transdermal Healthcare Systems. [PDF]

Adv Healthc Mater
Han J, Choi YJ, Kang SK.
europepmc   +1 more source

Dr. A. Cahid Civelek Exemplifies the Act of Integrating Patient Care, Staff Education, Research, and Global Knowledge Sharing. [PDF]

Mol Imaging Radionucl Ther
Zhang H.
europepmc   +1 more source

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial. [PDF]

Nat Med
Yap TA, Sweis RF, Vaishampayan U, Kilari D, Gainor JF, McKean M, Barve M, Tarhini AA, Bockorny B, Sonpavde G, Park D, Babu S, Ju Y, Liu L, Henry S, Tirucherai GS, DeWall S, Qatanani M, Marantz JL, Gan L.   +19 more
europepmc   +1 more source

No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with Bevacizumab. [PDF]

Liver Cancer
Jeschke M, Schütte JM, Himmen S, Herrmann K, Steinberg-Vorhoff HL, Theysohn JM, Best J, Schmidt HH, Jochheim LS.   +8 more
europepmc   +1 more source

Baseline PARP-1 PET imaging in patients with advanced solid tumors with DNA damage response mutations. [PDF]

Eur J Nucl Med Mol Imaging
Daoud T, Chen J, Wei P, Wong F, Yap TA, Lin LL.   +5 more
europepmc   +1 more source